Literature DB >> 26921739

Significant IFNγ responses of CD8+ T cells in CMV-seropositive individuals with autoimmune arthritis.

Giovanni Almanzar1, Marc Schmalzing2, Raimund Trippen3, Kerstin Höfner3, Benedikt Weißbrich4, Eva Geissinger5, Thomas Meyer6, Johannes Liese3, Hans-Peter Tony2, Martina Prelog3.   

Abstract

BACKGROUND: Latent Cytomegalovirus (CMV) infection accelerates immunosenescence in elderly with reactivations reported in Rheumatoid Arthritis (RA) and abnormal responses towards CMV in Juvenile Idiopathic Arthritis (JIA).
OBJECTIVES: Considering the signs of premature T-cell immunosenescence in arthritis patients, the known effect of CMV latency on speeding up many of these signs in an age-dependent manner and the role of CMV on IFNγ-mediated inflammation in healthy elderly and RA, we hypothesized that latent CMV infection accelerates TCR repertoire restriction, loss of CD28, peripheral T-cell proliferation and aberrant IFNγ responses in arthritis patients. STUDY
DESIGN: Unspecific and CMVpp65-specific IFNγ responses were investigated in peripheral CD8+ T-cells in RA or JIA patients and healthy, age-matched controls.
RESULTS: Despite higher prevalence and concentrations of IgG-anti-CMV, arthritis patients showed lower unspecific IFNγ production, lower CD69-mediated activation and lower CD8+ T-cell proliferation. CMV-seropositive RA patients showed higher intracellular IFNγ production and increased proportions of CD28-CD8+ T-cells after specific CMVpp65 long-term stimulation which was not altered by in vitro blockade of TNFα or IL-6. A skewed TCR repertoire towards oligoclonality and less polyclonality was found in JIA. DISCUSSION: CMVpp65-specific IFNγ production with expansion of CD28-CD8+ T-cells suggests an efficient control of latent CMV regardless of immunosuppressive therapy or in vitro blockade of TNFα or IL-6 in CMV-seropositive arthritis patients. Increased IgG-anti-CMV antibody concentrations and increased proportions of intracellular IFNγ-producing CMVpp65-specific CD8+ T-cells in long-term cultures propose a possibly role of endogenous CMV reactivations boosting antibody levels and a higher possibly CMV-driven IFNγ-mediated inflammatory potential of CD8+ T-cells in arthritis patients.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-IL-6; Anti-TNFα; CMV; IFNγ; JIA; RA

Mesh:

Substances:

Year:  2016        PMID: 26921739     DOI: 10.1016/j.jcv.2016.02.010

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  6 in total

1.  Characterization of senescence biomarkers in rheumatoid arthritis: relevance to disease progression.

Authors:  Laura E Petersen; Jaqueline B Schuch; Lucas A de Azeredo; Talita S A Baptista; Julia G Motta; Aline D do Prado; Moisés Evandro Bauer
Journal:  Clin Rheumatol       Date:  2019-06-11       Impact factor: 2.980

2.  T-cell phenotypes are associated with serum IgE levels in Amish and Hutterite children.

Authors:  Cara L Hrusch; Michelle M Stein; Justyna Gozdz; Mark Holbreich; Erika von Mutius; Donata Vercelli; Carole Ober; Anne I Sperling
Journal:  J Allergy Clin Immunol       Date:  2019-08-08       Impact factor: 10.793

Review 3.  Cytomegalovirus infection: friend or foe in rheumatoid arthritis?

Authors:  Jean-Luc Davignon; Bernard Combe; Alain Cantagrel
Journal:  Arthritis Res Ther       Date:  2021-01-07       Impact factor: 5.156

Review 4.  Human Cytomegalovirus and Autoimmune Diseases: Where Are We?

Authors:  Francesca Gugliesi; Selina Pasquero; Gloria Griffante; Sara Scutera; Camilla Albano; Sergio Fernando Castillo Pacheco; Giuseppe Riva; Valentina Dell'Oste; Matteo Biolatti
Journal:  Viruses       Date:  2021-02-08       Impact factor: 5.048

Review 5.  Accelerated immunosenescence in rheumatoid arthritis: impact on clinical progression.

Authors:  Moisés E Bauer
Journal:  Immun Ageing       Date:  2020-03-09       Impact factor: 6.400

Review 6.  CD8+ T Cell Senescence: Lights and Shadows in Viral Infections, Autoimmune Disorders and Cancer.

Authors:  Valentina Tedeschi; Giorgia Paldino; Martina Kunkl; Marino Paroli; Rosa Sorrentino; Loretta Tuosto; Maria Teresa Fiorillo
Journal:  Int J Mol Sci       Date:  2022-03-21       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.